Dr. Diane Chushin Ling, MD

Dr. Ling practices at USC Norris Cancer Hospital in Los Angeles, California.

Dr. Ling's NPI, 1093100927, was assigned on March 28, 2015. Dr. Ling graduated from University of Pittsburgh School of Medicine in 2015. Dr. Ling holds California license A168533.

Dr. Ling's primary practice is USC Norris Cancer Hospital, at 1441 Eastlake Ave, Los Angeles, CA.

Dr. Ling's primary practice is USC Norris Cancer Hospital in Los Angeles, California. Dr. Ling is also affiliated with Keck Hospital of USC. The medical group on file is USC Care Medical Group. Dmand AI also links Dr. Ling to 1 more hospital, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ling practices, 3 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Dr. Ling's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Ling is board certified in radiation oncology by the American Board of Radiology. Dmand AI has Dr. Ling's licenses on file in 2 states: California and Pennsylvania.

Dmand AI lists bone cancer radiation, breast cancer radiation, cancer radiation-upper GI, colorectal cancer radiation, lung cancer radiation and pancreatic cancer radiation among the conditions Dr. Ling treats.

CMS data shows 857 Medicare services from Dr. Ling across 17 procedure codes in 2024, for 123 Medicare patients. Medicare paid $65,505 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 123 Medicare patients who saw Dr. Ling in 2024. The largest group is 65 to 74, with 64 patients. 75% of them have cancer, and 75% have high blood pressure. 47% are also on Medicaid. Their average risk score is 2.84, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Ling's median patient age at 66, with 61% women.

In 2024, Dr. Ling wrote 15 Medicare Part D claims. 93% of them were for generic drugs.

Dr. Ling accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Ling as offering telehealth.

Dmand AI links 18 papers to Dr. Ling, published from 2013 to 2024. 2019 was the busiest year, with 3. The most frequent topics are Carcinoma, Squamous Cell. Dr. Ling's most frequent co-authors are Sushil Beriwal, MD, Dwight Earl Heron, MD and Steven A. Burton, MD.

CMS Open Payments shows 11 general payments to Dr. Ling from 6 drug and device companies from 2016 to 2024. Food and beverage make up the largest share, 100% of the total. Siemens Medical Solutions USA, Inc. paid the most, $445.

Dmand AI lists 1 award for Dr. Ling.

Dr. Ling graduated from University of Pittsburgh School of Medicine in 2015.

Dr. Ling is in network with 9 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.